The present invention provides a prophylactic and/or therapeutic agent for a neurodegenerative disease selected from the group consisting of an Alzheimer's disease, a frontotemporal lobar degeneration, and α-synucleinopathy, said agent containing at least one Src/c-Ab1 pathway inhibitor.
PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE